Jerzy Madon
- Oncology top 2%
- Drug Transport and Resistance Mechanisms 5
- Pharmacology top 1%
- Microbial Natural Products and Biosynthesis 2
- Hepatology top 5%
- Microbiology top 10%
-
- Genomics and Phylogenetic Studies 8
- RNA and protein synthesis mechanisms 5
-
- Bacterial Genetics and Biotechnology 5
-
- Blood Coagulation and Thrombosis Mechanisms 4
- Multiple Myeloma Research and Treatments 2
-
- Trace Elements in Health 3
- Co-authors
- Bruno StiegerPeter J. MeierLukas LandmannBruno HagenbuchThomas GerloffAlan F. HofmannKarin FattingerGerd A. Kullak‐Ublick
- Journals
- Journal of Bacteriology (3 papers)European Journal of Biochemistry (2 papers)Journal of Thrombosis and Haemostasis (2 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Jerzy Madon
28 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 1.3k
- Pharmacology 266
- Pediatrics, Perinatology and Child Health 594
- Hepatology 146
- Microbiology 11
Countries citing papers authored by Jerzy Madon
This map shows the geographic impact of Jerzy Madon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerzy Madon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerzy Madon more than expected).
Fields of papers citing papers by Jerzy Madon
This network shows the impact of papers produced by Jerzy Madon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerzy Madon. The network helps show where Jerzy Madon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jerzy Madon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 23 | |
| 2 | 2014 | 12 | |
| 3 | 2013 | 16 | |
| 4 | 2013 | 2 | |
| 5 | 2012 | 72 | |
| 6 | 2011 | 8 | |
| 7 | 2010 | 14 | |
| 8 | 2000 | 171 | |
| 9 | 2000 | 425 | |
| 10 | 2000 | 7 | |
| 11 | The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liverbreakdown → | 1998 | 769 |
| 12 | 1997 | 90 | |
| 13 | 1996 | 13 | |
| 14 | 1995 | 23 | |
| 15 | 1990 | 7 | |
| 16 | 1989 | 24 | |
| 17 | 1988 | 6 | |
| 18 | 1987 | 37 | |
| 19 | 1986 | 20 | |
| 20 | 1983 | 12 |
About Jerzy Madon
Jerzy Madon is a scholar working on Microbiology, Hematology and Genetics, having authored 29 papers that have together received 2.0k indexed citations. Recurring topics across this work include Genomics and Phylogenetic Studies (8 papers), Drug Transport and Resistance Mechanisms (5 papers), Bacterial Genetics and Biotechnology (5 papers), RNA and protein synthesis mechanisms (5 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Trace Elements in Health (3 papers), Microbial Natural Products and Biosynthesis (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Oncology (1.3k citations), Pharmacology (266 citations) and Pediatrics, Perinatology and Child Health (594 citations). Jerzy Madon has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Bruno Stieger, Peter J. Meier, Lukas Landmann, Bruno Hagenbuch, Thomas Gerloff, Alan F. Hofmann, Peter J. Meier, Karin Fattinger, Gerd A. Kullak‐Ublick and Karl O. Stetter. Their work appears in journals such as Journal of Bacteriology, European Journal of Biochemistry, Journal of Thrombosis and Haemostasis, Molecular Pharmacology and Thrombosis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.